At last: Classification of human mammary cells elucidates breast cancer origins

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Current breast cancer classification systems are based on molecular evaluation of tumor receptor status and do not account for distinct morphological phenotypes. In other types of cancer, taxonomy based on normal cell phenotypes has been extremely useful for diagnosis and treatment strategies. In this issue of the JCI, Santagata and colleagues developed a breast cancer classification scheme based on characterization of healthy mammary cells. Reclassification of breast cancer cells and breast cancer tissue microarrays with this system correlated with prognosis better than the standard receptor status designation. This scheme provides a major advance toward our understanding of the origin of the cells in the breast and breast cancers.

Original languageEnglish (US)
Pages (from-to)478-480
Number of pages3
JournalJournal of Clinical Investigation
Volume124
Issue number2
DOIs
StatePublished - Feb 3 2014

Fingerprint

Breast
Breast Neoplasms
Phenotype
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

At last : Classification of human mammary cells elucidates breast cancer origins. / Cardiff, Robert; Borowsky, Alexander D.

In: Journal of Clinical Investigation, Vol. 124, No. 2, 03.02.2014, p. 478-480.

Research output: Contribution to journalArticle

@article{122b89a6fa734b058fa161c5b88750de,
title = "At last: Classification of human mammary cells elucidates breast cancer origins",
abstract = "Current breast cancer classification systems are based on molecular evaluation of tumor receptor status and do not account for distinct morphological phenotypes. In other types of cancer, taxonomy based on normal cell phenotypes has been extremely useful for diagnosis and treatment strategies. In this issue of the JCI, Santagata and colleagues developed a breast cancer classification scheme based on characterization of healthy mammary cells. Reclassification of breast cancer cells and breast cancer tissue microarrays with this system correlated with prognosis better than the standard receptor status designation. This scheme provides a major advance toward our understanding of the origin of the cells in the breast and breast cancers.",
author = "Robert Cardiff and Borowsky, {Alexander D}",
year = "2014",
month = "2",
day = "3",
doi = "10.1172/JCI73910",
language = "English (US)",
volume = "124",
pages = "478--480",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - At last

T2 - Classification of human mammary cells elucidates breast cancer origins

AU - Cardiff, Robert

AU - Borowsky, Alexander D

PY - 2014/2/3

Y1 - 2014/2/3

N2 - Current breast cancer classification systems are based on molecular evaluation of tumor receptor status and do not account for distinct morphological phenotypes. In other types of cancer, taxonomy based on normal cell phenotypes has been extremely useful for diagnosis and treatment strategies. In this issue of the JCI, Santagata and colleagues developed a breast cancer classification scheme based on characterization of healthy mammary cells. Reclassification of breast cancer cells and breast cancer tissue microarrays with this system correlated with prognosis better than the standard receptor status designation. This scheme provides a major advance toward our understanding of the origin of the cells in the breast and breast cancers.

AB - Current breast cancer classification systems are based on molecular evaluation of tumor receptor status and do not account for distinct morphological phenotypes. In other types of cancer, taxonomy based on normal cell phenotypes has been extremely useful for diagnosis and treatment strategies. In this issue of the JCI, Santagata and colleagues developed a breast cancer classification scheme based on characterization of healthy mammary cells. Reclassification of breast cancer cells and breast cancer tissue microarrays with this system correlated with prognosis better than the standard receptor status designation. This scheme provides a major advance toward our understanding of the origin of the cells in the breast and breast cancers.

UR - http://www.scopus.com/inward/record.url?scp=84893837510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893837510&partnerID=8YFLogxK

U2 - 10.1172/JCI73910

DO - 10.1172/JCI73910

M3 - Article

C2 - 24463442

AN - SCOPUS:84893837510

VL - 124

SP - 478

EP - 480

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -